Literature DB >> 21316406

Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C.

Tobias Müller1, Stephan Buch2, Thomas Berg3, Jochen Hampe2, Felix Stickel4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21316406     DOI： 10.1016/j.jhep.2011.01.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

Review 1.  The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.

Authors:  Amit G Singal; Hema Manjunath; Adam C Yopp; Muhammad S Beg; Jorge A Marrero; Purva Gopal; Akbar K Waljee
Journal:  Am J Gastroenterol       Date:  2014-01-21       Impact factor: 10.864

2.  Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression.

Authors:  Rosa Zampino; Nicola Coppola; Grazia Cirillo; Adriana Boemio; Carmine Minichini; Aldo Marrone; Maria Stanzione; Mario Starace; Emanuele Durante-Mangoni; Evangelista Sagnelli; Luciano Restivo; Giovanna Salzillo; Maria Chiara Fascione; Riccardo Nevola; Emanuele Miraglia Del Giudice; Luigi Elio Adinolfi
Journal:  World J Hepatol       Date:  2014-09-27

3.  Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.

Authors:  Kohichiroh Yasui; Takahisa Kawaguchi; Toshihide Shima; Hironori Mitsuyoshi; Kojiro Seki; Rei Sendo; Masayuki Mizuno; Yoshito Itoh; Fumihiko Matsuda; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2014-11-26       Impact factor: 7.527

4.  IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity?

Authors:  Luca Valenti; Edoardo Pulixi; Susanna La Spina
Journal:  Hepatol Int       Date:  2011-12-07       Impact factor: 6.047

Review 5.  Alcoholic liver disease and hepatitis C virus infection.

Authors:  Ignacio Novo-Veleiro; Lucía Alvela-Suárez; Antonio-Javier Chamorro; Rogelio González-Sarmiento; Francisco-Javier Laso; Miguel Marcos
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  PNPLA3 I148M polymorphism and progressive liver disease.

Authors:  Paola Dongiovanni; Benedetta Donati; Roberta Fares; Rosa Lombardi; Rosellina Margherita Mancina; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

7.  A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis.

Authors:  Jonas Rosendahl; Anke Tönjes; Dorit Schleinitz; Peter Kovacs; Johannes Wiegand; Claudia Ruffert; Moritz Jesinghaus; Robert Schober; Max Herms; Robert Grützmann; Hans-Ulrich Schulz; Felix Stickel; Jens Werner; Peter Bugert; Matthias Blüher; Michael Stumvoll; Stephan Böhm; Thomas Berg; Henning Wittenburg; Joachim Mössner; Rene te Morsche; Monique Derikx; Volker Keim; Heiko Witt; Joost P H Drenth
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

8.  PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

Authors:  Luca Valenti; Benedetta Maria Motta; Giorgio Soardo; Massimo Iavarone; Benedetta Donati; Angelo Sangiovanni; Alessia Carnelutti; Paola Dongiovanni; Raffaela Rametta; Cristina Bertelli; Floriana Facchetti; Massimo Colombo; Silvia Fargion; Anna Ludovica Fracanzani
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population.

Authors:  Mariana Lazo; Usama Bilal; Mack C Mitchell; James Potter; Ruben Hernaez; Jeanne M Clark
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-31       Impact factor: 11.382

10.  Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.

Authors:  Stella De Nicola; Paola Dongiovanni; Alessio Aghemo; Cristina Cheroni; Roberta D'Ambrosio; Michele Pedrazzini; Francesco Marabita; Lorena Donnici; Marco Maggioni; Silvia Fargion; Massimo Colombo; Raffaele De Francesco; Luca Valenti
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.